CPHI vs PH
China Pharma Holdings Inc (CPHI) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CPHI currently screens at market cap $29.0M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CPHI and PH stock pages for the full models.
Not investment advice.